Addressing Infectious Disease Outbreaks
LabWare's Portable Disease Surveillance Lab (PDSL) is a cutting-edge solution designed to combat infectious disease outbreaks such as COVID-19. With a focus on rapid turnaround times for testing and efficient results distribution, the PDSL offers a comprehensive approach to disease surveillance.
Integrated with LIMS Technology
The core of the Portable Disease Lab kit is its seamless integration with LabWare LIMS software. Equipped with tablet devices, a Wi-Fi hotspot for cloud connectivity, a battery pack, wireless label printer, and an optional portable analyzer for COVID-19 testing, the PDSL ensures efficient data management and analysis.
Efficient Data Tracking and Dissemination
By directly connecting to the LabWare LIMS portal, the PDSL enables real-time tracking of patient demographic and clinical information. This streamlined process includes documenting field collection of respiratory swabs, accessing samples, and rapidly disseminating data to public health agencies. This enables swift and informed decision-making during disease outbreaks.
Multi-Target Testing Capability
In partnership with a leading molecular diagnostic company, LabWare offers a respiratory panel assay that can detect COVID-19, Flu A, Flu B, and RSV simultaneously from a single sample. This multi-target testing approach provides patients with accurate diagnoses, allowing for target-specific treatments and improved clinical outcomes.
Testimonials and Endorsements
Praise for LabWare's PDSL has come from notable figures like Chris Coons, U.S. Senator of Delaware, who commended the system's innovation and potential impact on the nation's response to the COVID-19 pandemic. Such endorsements underscore the significance of LabWare's contribution to disease surveillance and public health.